Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
18.8M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
2.21M
-
Shares change
-
-951K
-
Total reported value, excl. options
-
$6.6M
-
Value change
-
-$3.79M
-
Number of buys
-
18
-
Number of sells
-
-3
-
Price
-
$2.99
Significant Holders of Medicus Pharma Ltd. - Common shares, no par value (MDCX) as of Q2 2025
23 filings reported holding MDCX - Medicus Pharma Ltd. - Common shares, no par value as of Q2 2025.
Medicus Pharma Ltd. - Common shares, no par value (MDCX) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.21M shares
of 18.8M outstanding shares and own 11.76% of the company stock.
Largest 10 shareholders include Interchange Capital Partners, LLC (1.59M shares), Private Advisor Group, LLC (146K shares), Yorkville Advisors Global, LP (106K shares), GUYASUTA INVESTMENT ADVISORS INC (76.9K shares), Verition Fund Management LLC (53.4K shares), SeaCrest Wealth Management, LLC (46.6K shares), CITADEL ADVISORS LLC (41.1K shares), May Hill Capital, LLC (35.6K shares), UBS Group AG (30.9K shares), and BlackRock, Inc. (15.8K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.